Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: January 23, 2014
Event: Entry into material definitive agreements to acquire a majority stake in Celesio AG and creation of a direct financial obligation to fund the transaction.
Key Financial Metrics and Transaction Details
- Acquisition Value: Approximately €3.7 billion (approx. $5.1 billion at $1.37/€1 exchange rate).
- Share Purchase: Acquisition of ~75.99% of Celesio shares from Franz Haniel & Cie. GmbH at €23.50 per share.
- Bond Purchase: Acquisition of convertible bonds from the Elliott Group (4,840 bonds due 2014 and 2,180 bonds due 2018).
- Financing Facility: $5.5 billion 364-day unsecured Senior Bridge Term Loan.
- Debt Covenant: McKesson must maintain a debt-to-capital ratio of no greater than 65% during the loan term.
- Expected Closing: February 6, 2014.
Material Changes and Agreements
On January 23, 2014, McKesson and its subsidiary Dragonfly GmbH & Co. KGaA executed three primary agreements:
- Amended and Restated Share Purchase Agreement (SPA): To acquire the majority stake from Haniel.
- Bond Purchase Agreement (BPA): To acquire convertible bonds from the Elliott Group, enabling McKesson to achieve over 75% ownership on a fully diluted basis upon conversion.
- Amendment to Business Combination Agreement (BCA): Adjusting the October 2013 agreement to reflect the new SPA and BPA terms.
Following these agreements, McKesson announced a voluntary public tender offer for the remaining Celesio shares.
Outlook, Risks, and Management Commentary
- Financing Strategy: The $5.5 billion bridge loan is intended to fund the acquisition and transaction costs prior to the closing of anticipated permanent financing. McKesson expects to refinance all or part of this loan before the 364-day term expires.
- Covenants and Restrictions: The bridge loan includes standard limitations on creating liens, engaging in mergers, and entering swap contracts. It also mandates prepayments from net cash proceeds of certain equity issuances, asset sales, or property loss events.
- Regulatory Disclosure: The filing includes a press release (Exhibit 99.1) regarding the acquisition and tender offer, furnished under Regulation FD.
Investor Verification Checklist
- Verify the final closing date of the SPA and BPA (expected February 6, 2014).
- Monitor the success of the voluntary public tender offer for remaining Celesio shares.
- Track the execution of permanent financing to replace the $5.5 billion bridge loan.
- Review the impact of the 65% debt-to-capital ratio covenant on future capital allocation.
- Confirm the final exchange rate used for the transaction valuation if it deviates from the $1.37/€1 assumption.